Maalouf, Naim M.

Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents

Bedimo, R., Maalouf, N. M., Zhang, S., Drechsler, H., & Tebas, P. (2012) · AIDS

HIV-related health complications and treatmentsHIV/AIDS drug development and treatment

Cited by 324

The effects of smoking on bone metabolism

Yoon, V., Maalouf, N. M., & Sakhaee, K. (2012) · Osteoporosis International

Bone health and osteoporosis researchBone Metabolism and Diseases

Cited by 268

The Role of Receptor Activator of Nuclear Factor-κB (RANK)/RANK Ligand/Osteoprotegerin: Clinical Implications

Vega, D., Maalouf, N. M., & Sakhaee, K. (2007) · The Journal of Clinical Endocrinology & Metabolism

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 246

Biochemical and stone-risk profiles with topiramate treatment

Welch, B. J., Graybeal, D., Moe, O. W., Maalouf, N. M., & Sakhaee, K. (2006) · American Journal of Kidney Diseases

Kidney Stones and Urolithiasis TreatmentsGout, Hyperuricemia, Uric Acid

Cited by 126